Sigma-Tau sales and marketing update

Sigma-Tau launched Cystaran cysteamine ophthalmic solution in the U.S. to treat corneal cystine crystal accumulation in patients with cystinosis, a rare genetic lysosomal storage disease. Cystaran, a...